3
|
Montamat-Sicotte DJ, Millington KA, Willcox CR, Hingley-Wilson S, Hackforth S, Innes J, Kon OM, Lammas DA, Minnikin DE, Besra GS, Willcox BE, Lalvani A. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 2011; 121:2493-503. [PMID: 21576820 PMCID: PMC3104771 DOI: 10.1172/jci46216] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2010] [Accepted: 03/30/2011] [Indexed: 11/17/2022] Open
Abstract
Current tuberculosis (TB) vaccine strategies are largely aimed at activating conventional T cell responses to mycobacterial protein antigens. However, the lipid-rich cell wall of Mycobacterium tuberculosis (M. tuberculosis) is essential for pathogenicity and provides targets for unconventional T cell recognition. Group 1 CD1-restricted T cells recognize mycobacterial lipids, but their function in human TB is unclear and their ability to establish memory is unknown. Here, we characterized T cells specific for mycolic acid (MA), the predominant mycobacterial cell wall lipid and key virulence factor, in patients with active TB infection. MA-specific T cells were predominant in TB patients at diagnosis, but were absent in uninfected bacillus Calmette-Guérin-vaccinated (BCG-vaccinated) controls. These T cells were CD1b restricted, detectable in blood and disease sites, produced both IFN-γ and IL-2, and exhibited effector and central memory phenotypes. MA-specific responses contracted markedly with declining pathogen burden and, in patients followed longitudinally, exhibited recall expansion upon antigen reencounter in vitro long after successful treatment, indicative of lipid-specific immunological memory. T cell recognition of MA is therefore a significant component of the acute adaptive and memory immune response in TB, suggesting that mycobacterial lipids may be promising targets for improved TB vaccines.
Collapse
Affiliation(s)
- Damien J. Montamat-Sicotte
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Kerry A. Millington
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Carrie R. Willcox
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Suzie Hingley-Wilson
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Sarah Hackforth
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - John Innes
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Onn Min Kon
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - David A. Lammas
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - David E. Minnikin
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Gurdyal S. Besra
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Benjamin E. Willcox
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| | - Ajit Lalvani
- Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Birmingham Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, United Kingdom.
Tuberculosis Service, Chest and Allergy Clinic, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Division of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
| |
Collapse
|
5
|
Scharf L, Li NS, Hawk AJ, Garzón D, Zhang T, Fox LM, Kazen AR, Shah S, Haddadian EJ, Gumperz JE, Saghatelian A, Faraldo-Gómez JD, Meredith SC, Piccirilli JA, Adams EJ. The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 2010; 33:853-62. [PMID: 21167756 PMCID: PMC3010391 DOI: 10.1016/j.immuni.2010.11.026] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2010] [Revised: 09/20/2010] [Accepted: 11/25/2010] [Indexed: 11/30/2022]
Abstract
CD1 molecules function to present lipid-based antigens to T cells. Here we present the crystal structure of CD1c at 2.5 Å resolution, in complex with the pathogenic Mycobacterium tuberculosis antigen mannosyl-β1-phosphomycoketide (MPM). CD1c accommodated MPM's methylated alkyl chain exclusively in the A' pocket, aided by a unique exit portal underneath the α1 helix. Most striking was an open F' pocket architecture lacking the closed cavity structure of other CD1 molecules, reminiscent of peptide binding grooves of classical major histocompatibility complex molecules. This feature, combined with tryptophan-fluorescence quenching during loading of a dodecameric lipopeptide antigen, provides a compelling model by which both the lipid and peptide moieties of the lipopeptide are involved in CD1c presentation of lipopeptides.
Collapse
Affiliation(s)
- Louise Scharf
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
| | - Nan-Sheng Li
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
| | - Andrew J. Hawk
- Department of Pathology, University of Chicago, Chicago, USA
| | - Diana Garzón
- Theoretical Molecular Biophysics Group, Max Planck Institute of Biophysics, Frankfurt am Main, Germany
| | - Tejia Zhang
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, USA
| | - Lisa M. Fox
- Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Allison R. Kazen
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
| | - Sneha Shah
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
| | - Esmael J. Haddadian
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
| | - Jenny E. Gumperz
- Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Alan Saghatelian
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, USA
| | - José D. Faraldo-Gómez
- Theoretical Molecular Biophysics Group, Max Planck Institute of Biophysics, Frankfurt am Main, Germany
- Cluster of Excellence ‘Macromolecular Complexes’, Goethe University Frankfurt, Frankfurt am Main, Germany
| | - Stephen C. Meredith
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
- Department of Pathology, University of Chicago, Chicago, USA
| | - Joseph A. Piccirilli
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
- Department of Chemistry, University of Chicago, Chicago, USA
| | - Erin J. Adams
- Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA
- Committee on Immunology, University of Chicago, Chicago, USA
| |
Collapse
|
6
|
Harris SP, Fujiwara N, Mealey RH, Alperin DC, Naka T, Goda R, Hines SA. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. MICROBIOLOGY (READING, ENGLAND) 2010; 156:1836-1847. [PMID: 20299405 PMCID: PMC4086205 DOI: 10.1099/mic.0.035915-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/30/2009] [Revised: 03/15/2010] [Accepted: 03/16/2010] [Indexed: 01/14/2023]
Abstract
Immune adult horses have CD8(+) cytotoxic T lymphocytes (CTLs) that recognize and lyse Rhodococcus equi-infected cells in an equine lymphocyte alloantigen (ELA)-A [classical major histocompatibility complex (MHC) class I]-unrestricted fashion. As protein antigens are MHC class I-restricted, the lack of restriction suggests that the bacterial antigens being recognized by the host are not proteins. The goals of this study were to test the hypothesis that these CTLs recognize unique R. equi cell-wall lipids related to mycobacterial lipids. Initial experiments showed that treatment of soluble R. equi antigen with broadly reactive proteases did not significantly diminish the ability of the antigen to stimulate R. equi-specific CTLs. R. equi-specific CTLs were also shown to lyse target cells (equine macrophages) pulsed with an R. equi lipid extract. Analysis of the R. equi lipid by TLC and MS (MALDI-TOF and ES) indicated that the extracted antigen consisted of three primary fractions: trehalose monomycolate (TMM), trehalose dimycolate (TDM) and cardiolipin (CL). ELA-A-mismatched cells pulsed with purified TMM and CL, but not the TDM fraction, were recognized and lysed by R. equi-specific CTLs. Because of their role in immune clearance and pathogenesis, transcription of the cytokines gamma interferon (IFN-gamma) and interleukin-4 (IL-4) was also measured in response to R. equi lipids by using real-time PCR; elevated IFN-gamma, but not IL-4, was associated with host clearance of the bacteria. The whole-cell R. equi lipid and all three R. equi lipid fractions resulted in marked increases in IFN-gamma transcription, but no increase in IL-4 transcription. Together, these data support the hypothesis that immune recognition of unique lipids in the bacterial cell wall is an important component of the protective immune response to R. equi. The results also identify potential lipid antigens not previously shown to be recognized by CTLs in an important, naturally occurring actinomycete bacterial pathogen.
Collapse
Affiliation(s)
- Seth P. Harris
- Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA
| | - Nagatoshi Fujiwara
- Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan
| | - Robert H. Mealey
- Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA
| | - Debra C. Alperin
- Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA
| | - Takashi Naka
- Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan
| | - Reina Goda
- Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan
| | - Stephen A. Hines
- Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA
| |
Collapse
|